Sources of preanalytical error in pharmacokinetic analyses – focus on intravenous drug administration and collection of blood samples

Bibliography

• Pharmacokinetic Studies in Man (3CC3A). European Medicines Agency. London. 1988. Available from: http://www.ema.europa.eu/docs/en_GB/document_library/Scientific_guideline/2009/09/WC500003127.pdf [Last accessed 24 February 2014]
   Google Scholar
• Center for Drug Evaluation and Research (CDER), Center for Biologics Evaluation and Research (CBER), Food and Drug Administration. Guidance for industry: population pharmacokinetics. Rockville, USA; 1999. Available from: http://www.fda.gov/downloads/drugs/guidancecomplianceregulatoryinformation/guidances/ucm072137.pdf [Last accessed 24 February 2014]
   Google Scholar
• Committe for Medicinal products for Human Use (CHMP), European Medicines Agency. Guideline on the role of pharmacokinetics in the development of medicinal products in the paediatric population (CHMP/EWP/147013/04). London; 2006. Available from: http://www.ema.europa.eu/docs/en_GB/document_library/Scientific_guideline/2009/09/WC500003066.pdf [Last accessed 24 February 2014]
   Google Scholar
• Ethical considerations for clinical trials on medicinal products conducted with the paediatric population. (Recommendations of the ad hoc group for the development of implementing guidelines for Directive 2001/20/EC relating to good clinical practice in the conduct of clinical trials onmedicinal products for human use). London. 2008. Available from: ftp://ftp.cordis.europa.eu/pub/fp7/docs/ethical-considerations-paediatrics_en.pdf [Last accessed on 24 February 2014]
   Google Scholar
• Center for Drug Evaluation and Research (CDER), Center for Biologics Evaluation and Research (CBER), Food and Drug Administration. Guidance for industry: general considerations for paediatric PK studies for drugs and biological products (Draft guidance). Rockville, USA; 1998. Available from: http://www.fda.gov/downloads/Drugs/GuidanceComplianceRegulatoryInformation/Guidances/ucm072114.pdf [Last accessed 24 February 2014]
   Google Scholar
• Committe for Medicinal products for Human Use (CHMP), European Medicines Agency. Guideline on the investigation of medicinal products in the term and preterm neonate (EMEA/536810/08). London; 2007. Available from: http://www.ema.europa.eu/docs/en_GB/document_library/Scientific_guideline/2009/09/WC500003750.pdf [Last accessed 24 February 2014]
   Google Scholar
• Lovich MA, Peterfreund GL, Sims NM, Peterfreund RA. Central venous catheter infusions: a laboratory model shows large differences in drug delivery dynamics related to catheter dead volume. Crit Care Med 2007;35(12):2792-8
   PubMed Web of Science ®Google Scholar
• Kontny NE, Boos J, Wurthwein G, et al. Minimization of the preanalytical error in pharmacokinetic analyses and therapeutic drug monitoring: focus on IV drug administration. Ther Drug Monit 2012;34(4):460-6
   PubMed Web of Science ®Google Scholar
• Peterfreund RA, Philip JH. Critical parameters in drug delivery by intravenous infusion. Expert Opin Drug Deliv 2013;10(8):1095-108
   PubMed Web of Science ®Google Scholar
• Lovich MA, Kinnealley ME, Sims NM, Peterfreund RA. The delivery of drugs to patients by continuous intravenous infusion: modeling predicts potential dose fluctuations depending on flow rates and infusion system dead volume. Anesth Analg 2006;102(4):1147-53
   PubMed Web of Science ®Google Scholar
• Weiss M, Banziger O, Neff T, Fanconi S. Influence of infusion line compliance on drug delivery rate during acute line loop formation. Intensive Care Med 2000;26(6):776-9
   PubMed Web of Science ®Google Scholar
• Weiss M, Hug MI, Neff T, Fischer J. Syringe size and flow rate affect drug delivery from syringe pumps. Can J Anaesth 2000;47(10):1031-5
   PubMed Web of Science ®Google Scholar
• Boos J, Bomelburg T, Gerding H, Jurgens H. Is there a relationship between cytarabine pharmacokinetics and keratitis? – a case report. Int J Clin Pharmacol Ther Toxicol 1993;31(12):593-6
   PubMedGoogle Scholar
• Flege S, Hempel G, Schulze-Westhoff P, et al. Drug monitoring of doxorubicin in children. In: Hiddemann W, et al. editors. Haematology and blood transfusion 40 - acute leukemias VIII - experimental approaches and novel therapies. Springer Verlag, Buchband; 2001:S231-5
   Google Scholar
• Smith JC, Davies MC, Melia CD, et al. Uptake of drugs by catheters: the influence of the drug molecule on sorption by polyurethane catheters. Biomaterials 1996;17(15):1469-72
   PubMed Web of Science ®Google Scholar
• Medlicott NJ, Reith DM, McCaffrey F, et al. Delayed delivery of intravenous gentamicin in neonates: impact of infusion variables. J Pharm Pharmacol 2013;65(3):370-8
   PubMed Web of Science ®Google Scholar
• Boos J. Behandlungsfehler aus Sicht des Mediziners. In: von Eiff W, editor. Patientenorientierte Arzneimittelversorgung, Hrsg. Thieme Verlag, 2011:S1-17
   Google Scholar
• Roberts RJ. Issues and problems associated with drug delivery in pediatric patients. J Clin Pharmacol 1994;34(7):723-4
   PubMed Web of Science ®Google Scholar
• Anh AVQ, Norris RLG, Charles BC. Modelling drug loss during intravenous infusion to premature neonates. J Pharm Pract Res 2006;36:262-5
   Google Scholar
• Cole M, Boddy AV, Kearns P, et al. Potential clinical impact of taking multiple blood samples for research studies in paediatric oncology: how much do we really know? Pediatr Blood Cancer 2006;46(7):723-7
   PubMed Web of Science ®Google Scholar
• Kauffman RE. Clinical trials in children: problems and pitfalls. Paediatr Drugs 2000;2(6):411-18
   PubMedGoogle Scholar
• Bachmann MB, Biscoping J, Adams HA, et al. [The significance of the sampling site in the determination of plasma levels of local anesthetics using 0.75% bupivacaine as an example]. Reg Anaesth 1990;13(1):16-20
   PubMedGoogle Scholar
• Landers S, Berry PL, Kearns GL, et al. Gentamicin disposition and effect on development of renal function in the very low birth weight infant. Dev Pharmacol Ther 1984;7(5):285-302
   PubMedGoogle Scholar
• Palm C, Bjork O, Bjorkholm M, Eksborg S. Quantification of doxorubicin in plasma – a comparative study of capillary and venous blood sampling. Anticancer Drugs 2001;12(10):859-64
   PubMed Web of Science ®Google Scholar
• Bomelburg T, Ritter J, Schellong G. [Determination of methotrexate concentration in serum: comparison between capillary and venous blood]. Klin Padiatr 1987;199(3):230-2
   PubMed Web of Science ®Google Scholar
• Lewis AS, Taylor G, Williams HO, Lewis MH. Comparison of venous and capillary blood sampling for the clinical determination of tobramycin serum concentrations. Br J Clin Pharmacol 1985;20(6):597-601
   PubMed Web of Science ®Google Scholar
• Murphy JE, Peltier T, Anderson D, Ward ES. A comparison of venous versus capillary measurements of drug concentration. Ther Drug Monit 1990;12(3):264-7
   PubMed Web of Science ®Google Scholar
• Dayre McNally J, Matheson LA, Sankaran K, Rosenberg AM. Capillary blood sampling as an alternative to venipuncture in the assessment of serum 25 hydroxyvitamin D levels. J Steroid Biochem Mol Biol 2008;112(1-3):164-8
   PubMed Web of Science ®Google Scholar
• Kauffman RE, Kearns GL. Pharmacokinetic studies in paediatric patients. Clinical and ethical considerations. Clin Pharmacokinet 1992;23(1):10-29
   PubMed Web of Science ®Google Scholar
• Keller CA. Methods of drawing blood samples through central venous catheters in pediatric patients undergoing bone marrow transplant: results of a national survey. Oncol Nurs Forum 1994;21(5):879-84
   PubMedGoogle Scholar
• Cole M, Price L, Parry A, et al. A study to determine the minimum volume of blood necessary to be discarded from a central venous catheter before a valid sample is obtained in children with cancer. Pediatr Blood Cancer 2007;48(7):687-95
   PubMed Web of Science ®Google Scholar
• Odum L, Drenck NE. Blood sampling for biochemical analysis from central venous catheters: minimizing the volume of discarded blood. Clin Chem Lab Med 2002;40(2):152-5
   PubMed Web of Science ®Google Scholar
• Kontny NE, Hempel G, Boos J, et al. Minimization of the preanalytical error in plasma samples for pharmacokinetic analyses and therapeutic drug monitoring – using doxorubicin as an example. Ther Drug Monit 2011;33(6):766-71
   PubMed Web of Science ®Google Scholar
• Frey AM. Drawing blood samples from vascular access devices: evidence-based practice. J Infus Nurs 2003;26(5):285-93
   PubMedGoogle Scholar
• Barton SJ, Chase T, Latham B, Rayens MK. Comparing two methods to obtain blood specimens from pediatric central venous catheters. J Pediatr Oncol Nurs 2004;21(6):320-6
   PubMedGoogle Scholar
• Holmes KR. Comparison of push-pull versus discard method from central venous catheters for blood testing. J Intraven Nurs 1998;21(5):282-5
   PubMedGoogle Scholar
• Adlard K. Examining the push-pull method of blood sampling from central venous access devices. J Pediatr Oncol Nurs 2008;25(4):200-7
   PubMed Web of Science ®Google Scholar
• Cosca PA, Smith S, Chatfield S, et al. Reinfusion of discard blood from venous access devices. Oncol Nurs Forum 1998;25(6):1073-6
   PubMedGoogle Scholar
• Shulman RJ, Ou C, Reed T, Gardner P. Central venous catheters versus peripheral veins for sampling blood levels of commonly used drugs. JPEN J Parenter Enteral Nutr 1998;22(4):234-7
   PubMed Web of Science ®Google Scholar
• Franson TR, Ritch PS, Quebbeman EJ. Aminoglycoside serum concentration sampling via central venous catheters: a potential source of clinical error. JPEN J Parenter Enteral Nutr 1987;11(1):77-9
   PubMed Web of Science ®Google Scholar
• Longley JM, Murphy JE. Falsely elevated digoxin levels: another look. Ther Drug Monit 1989;11(5):572-3
   PubMed Web of Science ®Google Scholar
• Murphy JE, Ward ES. Elevated phenytoin concentration caused by sampling through the drug-administration catheter. Pharmacotherapy 1991;11(4):348-50
   PubMed Web of Science ®Google Scholar
• Wanwimolruk S, Murphy JE. Effect of monitoring drug concentrations through lines used to administer the drugs: an in vitro study. Ther Drug Monit 1991;13(5):443-7
   PubMed Web of Science ®Google Scholar
• Grouzmann E, Buclin T, Biollaz J. Misleading tacrolimus concentration value in blood taken from a catheter used for tacrolimus administration. Am J Health Syst Pharm 2008;65(3):226-8
   PubMed Web of Science ®Google Scholar
• Wright DF, Al-Sallami HS, Jackson PM, Reith DM. Falsely elevated vancomycin plasma concentrations sampled from central venous implantable catheters (portacaths). Br J Clin Pharmacol 2010;70(5):769-72
   PubMed Web of Science ®Google Scholar
• Cash M, Schafhauser B, Byers JF. Venipuncture versus central venous access: a comparison of methotrexate levels in pediatric leukemia patients. J Pediatr Oncol Nurs 1999;16(4):189-93
   PubMedGoogle Scholar
• Ritzmo C, Albertioni F, Cosic K, et al. Therapeutic drug monitoring of methotrexate on the pediatric oncology ward: can blood sampling from central venous accesses substitute for capillary finger punctures? Ther Drug Monit 2007;29(4):447-51
   PubMed Web of Science ®Google Scholar
• de Jonge ME, Mathot RA, van Dam SM, et al. Sorption of thiotepa to polyurethane catheter causes falsely elevated plasma levels. Ther Drug Monit 2003;25(3):261-3
   PubMed Web of Science ®Google Scholar
• Skolnik JM, Zhang AY, Barrett JS, Adamson PC. Approaches to clear residual chemotherapeutics from indwelling catheters in children with cancer. Ther Drug Monit 2010;32(6):741-8
   PubMed Web of Science ®Google Scholar
• McBeth CL, McDonald RJ, Hodge MB. Antibiotic sampling from central venous catheters versus peripheral veins. Pediatr Nurs 2004;30(3):200-2
   PubMedGoogle Scholar
• Boodhan S, Maloney AM, Dupuis LL. Extent of agreement in gentamicin concentration between serum that is drawn peripherally and from central venous catheters. Pediatrics 2006;118(6):e1650-6
   PubMed Web of Science ®Google Scholar
• Huitema AD, Holtkamp M, Tibben MM, et al. Sampling technique from central venous catheters proves critical for pharmacokinetic studies. Ther Drug Monit 1999;21(1):102-4
   PubMed Web of Science ®Google Scholar
• Groll AH, Silling G, Young C, et al. Randomized comparison of safety and pharmacokinetics of caspofungin, liposomal amphotericin B, and the combination of both in allogeneic hematopoietic stem cell recipients. Antimicrob Agents Chemother 2010;54(10):4143-9
   PubMed Web of Science ®Google Scholar
• Wurthwein G, Young C, Lanvers-Kaminsky C, et al. Population pharmacokinetics of liposomal amphotericin B and caspofungin in allogeneic hematopoietic stem cell recipients. Antimicrob Agents Chemother 2011;56(1):536-43
   PubMed Web of Science ®Google Scholar
• Edwards AY, Skolnik JM, Dombrowsky E, et al. Modeling and simulation approaches to evaluate pharmacokinetic sampling contamination from central venous catheters in pediatric pharmacokinetic studies of actinomycin-D: a report from the children's oncology group. Cancer Chemother Pharmacol 2011;70(1):83-94
   Web of Science ®Google Scholar